Fluorine and Health Molecular Imaging, Biomedical Materials and Pharmaceuticals

Enregistré dans:
Détails bibliographiques
Auteur principal: Tressaud, Alain (1943-....). (Auteur)
Autres auteurs: Haufe, Günter. (Auteur)
Support: E-Book
Langue: Anglais
Publié: San Diego, CA : Elsevier Science, 2008.
Autres localisations: Voir dans le Sudoc
Résumé: Fluorine and Health presents a critical multidisciplinary overview on the contribution of fluorinated compounds to resolve the important global issue of medicinal monitoring and health care. The involved subjects are organized in three thematic parts devoted to Molecular Imaging, Biomedical Materials and Pharmaceuticals. Initially the key-position of partially fluorinated low molecular weight compounds labelled either with the natural 19F-isotope for Magnetic Resonance Imaging (MRI) or labelled with the radioactive [18F]-isotope for Positron Emission Tomography (PET) is highlighted. Both non-invasive methods belong to the most challenging in vivo imaging techniques in oncology, neurology and in cardiology for the diagnosis of diseases having the highest mortality in the industrialized countries. The manifold facets of fluorinated biomaterials range from inorganic ceramics to perfluorinated organic molecules. Liquid perfluorocarbons are suitable for oxygen transport and as potential respiratory gas carriers, while fluorinated polymers are connected to the pathology of blood vessels. Another important issue concerns the application of highly fluorinated liquids in ophthalmology. Moreover, fluorine is an essential trace element in bone mineral, dentine and tooth enamel and is applied for the prophylaxis and treatment of dental caries. The various origins of human exposure to fluoride species is detailed to promote a better understanding of the effect of fluoride species on living organisms. Medicinally relevant fluorinated molecules and their interactions with native proteins are the main focus of the third part. New molecules fluorinated in strategic position are crucial for the development of pharmaceuticals with desired action and optimal pharmacological profile. Among the hundreds of marketed active drug components there are more than 150 fluorinated compounds. The chapters will illustrate how the presence of fluorine atoms alters properties of bioactive compounds at various biochemical steps, and possibly facilitate its emergence as pharmaceuticals. Finally the synthetic potential of a fluorinase, the first C-F bond forming enzyme, is summarized. - New approach of topics involving chemistry, biology and medicinal techniques - Transdisciplinar papers on fluoride products - Importance of fluoride products in health - Updated data on specific topics
Accès en ligne: Accès à l'E-book
LEADER 07055cmm a2200577 i 4500
001 ebook-170602133
005 20230112152844.0
007 cr|cuu---auauu
008 130712s20uu||||fr ||||g|||d ||||||eng d
020 |a 9780080558110 
020 |a 0080558119 (electronic bk) 
024 7 |a 10.1016/b978-0-444-53086-8.x0001-x  |2 DOI 
035 |a 182574857  |9 sudoc 
035 |a (OCoLC)679706703 
035 |a FRCYB88812014 
035 |a FRCYB07488812014 
035 |a FRCYB08288812014 
035 |a FRCYB14088812014 
035 |a FRCYB24288812014 
035 |a FRCYB26088812014 
035 |a FRCYB26888812014 
035 |a FRCYB29388812014 
035 |a FRCYB29588812014 
035 |a FRCYB55488812014 
035 |a FRCYB55988812014 
035 |a Elsevierocn272388851 
035 |a ocn272388851 
035 |a (OCoLC)272388851  |z (OCoLC)239300690  |z (OCoLC)646747428  |z (OCoLC)712978365  |z (OCoLC)775115782 
040 |a ABES  |b fre  |e AFNOR 
041 0 |a eng  |2 639-2 
100 1 |0 (IdRef)070006180  |1 http://www.idref.fr/070006180/id  |a Tressaud, Alain  |d (1943-....).  |4 aut.  |e Auteur 
245 1 0 |a Fluorine and Health  |h [Ressource électronique] :  |b Molecular Imaging, Biomedical Materials and Pharmaceuticals   |c Alain Tressaud. 
256 |a Données textuelles. 
264 1 |a San Diego, CA :  |b Elsevier Science,  |c 2008. 
336 |b txt  |2 rdacontent 
337 |b c  |2 rdamedia 
337 |b b  |2 isbdmedia 
500 |a Titre provenant de la page de titre du document numérique. 
500 |a Numérisation de l'édition de Amsterdam, Nederlands : Elsevier Science & Technology Books, 2008. 
500 |a La pagination de l'édition imprimée correspondante est de 820 p. 
506 |a L'accès complet à la ressource est réservé aux usagers des établissements qui en ont fait l'acquisition 
516 |a Fichier PDF. 
520 |a Fluorine and Health presents a critical multidisciplinary overview on the contribution of fluorinated compounds to resolve the important global issue of medicinal monitoring and health care. The involved subjects are organized in three thematic parts devoted to Molecular Imaging, Biomedical Materials and Pharmaceuticals. Initially the key-position of partially fluorinated low molecular weight compounds labelled either with the natural 19F-isotope for Magnetic Resonance Imaging (MRI) or labelled with the radioactive [18F]-isotope for Positron Emission Tomography (PET) is highlighted. Both non-invasive methods belong to the most challenging in vivo imaging techniques in oncology, neurology and in cardiology for the diagnosis of diseases having the highest mortality in the industrialized countries. The manifold facets of fluorinated biomaterials range from inorganic ceramics to perfluorinated organic molecules. Liquid perfluorocarbons are suitable for oxygen transport and as potential respiratory gas carriers, while fluorinated polymers are connected to the pathology of blood vessels. Another important issue concerns the application of highly fluorinated liquids in ophthalmology. Moreover, fluorine is an essential trace element in bone mineral, dentine and tooth enamel and is applied for the prophylaxis and treatment of dental caries. The various origins of human exposure to fluoride species is detailed to promote a better understanding of the effect of fluoride species on living organisms. Medicinally relevant fluorinated molecules and their interactions with native proteins are the main focus of the third part. New molecules fluorinated in strategic position are crucial for the development of pharmaceuticals with desired action and optimal pharmacological profile. Among the hundreds of marketed active drug components there are more than 150 fluorinated compounds. The chapters will illustrate how the presence of fluorine atoms alters properties of bioactive compounds at various biochemical steps, and possibly facilitate its emergence as pharmaceuticals. Finally the synthetic potential of a fluorinase, the first C-F bond forming enzyme, is summarized. - New approach of topics involving chemistry, biology and medicinal techniques - Transdisciplinar papers on fluoride products - Importance of fluoride products in health - Updated data on specific topics 
538 |a Configuration requise : navigateur internet. 
559 1 |b PART I: MOLECULAR IMAGING  |b 1. Fluorine-18 Chemistry for Molecular Imaging with Positron Emission Tomography  |b Frédéric Dollé, Dirk Roeda, Bertrand Kuhnast, and Marie-Claire Lasne  |b 2. Application of 18F-PET Imaging for the Study of Alzheimer's Disease  |b Kjell Någren and Juha O. Rinne  |b 3. 18F-Labeled PET-Tracers for Cardiological Imaging  |b Klaus Kopka, Stefan Wagner, Michael Sch̃fers, Andreas Faust, Otmar Schober, and Günter Haufe  |b 4. [18F]-Labeled PET and PET/CT Compounds in Oncology  |b Ken Herrmann and Bernd Joachim Krause  |b 5. Non-Invasive Physiology and Pharmacology Using 19F Magnetic Resonance  |b Jian-Xin Yu, Weina Cui, Dawen Zhao, and Ralph P. Mason  |b PART II: BIOMEDICAL MATERIALS  |b 6. Fluoride-Based Bioceramics  |b Christian Rey, Chrisẗle Combes, Christophe Drouet, and Hocine Sfihi  |b 7. Fluoride in Dentistry and Dental Restoratives  |b John W. Nicholson and Beata Czarnecka  |b 8. Fluorinated Biomaterials for Cardiovascular Surgery  |b Charles Baquey, Marie-Christine Durrieu, and Robert G. Guidoin  |b 9. Fluorinated Molecules in Eye Surgery: Experimental and Clinical Benefit of a Heavy Silicone Oil Oxane Hdʼ (Mixture of Silicone Oil and RMN3 Fluorine Olefin) in the Treatment of Retinal Detachment  |b I. Rico-Lattes, J.C. Quintyn, V. Pagot-Mathis, X. Benouaich, and A. Mathis  |b 10. Biocompatibility of Highly Fluorinated Liquids Used in Ophthalmic Surgery  |b Dirk-Henning Menz and Joachim H. Dresp  |b 11. Perfluorochemical-Based Oxygen Therapeutics, Contrast Agents, and Beyond  |b Marie Pierre Krafft and Jean G. Riess  |b 12. Exposure of Humans to Fluorine and Its Assessment  |b Maja Ponikvar  |b PART III: PHARMACEUTICALS  |b 13. Biological Impacts of Fluorination: Pharmaceuticals Based on Natural Products  |b Jean-Pierre Bégué and Danièle Bonnet-Delpon  |b 14. Synthesis and Pharmacological Properties of Fluorinated Prostanoids  |b Yasushi Matsumura  |b 15. Synthesis and Biochemical Evaluation of Fluorinated Monoamine Oxidase Inhibitors  |b Kenneth L. Kirk, Shinichi Yoshida, and Günter Haufe  |b 16. Fluoroolefin Dipeptide Isosteres: Structure, Syntheses, and Applications  |b John T. Welch  |b 17. Molecular Interactions of Fluorinated Amino Acids in a Native Polypeptide Environment  |b Mario Salwiczek, Christian J̃ckel, and Beate Koksch  |b 18. Biological Fluorination in Streptomyces cattleya: The Fluorinase  |b Hai Deng, Fang-Lu Huang, James H. Naismith, David O & prime;Hagan, Jonathan B. Spencer, and Xiaofeng Zhu 
700 1 |0 (IdRef)032349874  |1 http://www.idref.fr/032349874/id  |a Haufe, Günter.  |4 aut.  |e Auteur 
856 |u https://srvext.uco.fr/login?url=https://univ.scholarvox.com/book/88812014  |w Données éditeur  |z Accès à l'E-book 
886 2 |2 unimarc  |a 181  |a i#  |b xxxe## 
993 |a E-Book  
994 |a BNUM 
995 |a 170602133